Skip to main content

United Laboratories International Holdings

The United Laboratories International Holdings Ltd is a Hong Kong-headquartered pharmaceutical company manufacturing intermediate antibiotics, active pharmaceutical ingredients, and finished formulations. The company produces bulk amoxicillin, ampicillin, insulin formulations, and specialized human prescription drugs across China. Main revenue drivers include commercial sales of intermediate antibiotics, bulk active pharmaceutical ingredients, and finished insulin and antibiotic formulations to domestic and export markets. The United Laboratories serves hospital networks, medical institutions, prescription pharmacies, and international pharmaceutical companies across mainland China, Europe, and Asia. The company holds a market-leading position in China for bulk antibiotic intermediates and human insulin production. Headquartered in Hong Kong, it is listed on the Hong Kong Stock Exchange.

6 of the funds FundTelligence covers report a position in United Laboratories International Holdings.

Sector
Health Care
Country
Hong Kong SAR China
Funds holding it
6

Funds holding United Laboratories International Holdings

Loading...